Immunocontraception is induced in BALB/c mice inoculated with murine cytomegalovirus expressing mouse zona pellucida 3 - PubMed (original) (raw)
Immunocontraception is induced in BALB/c mice inoculated with murine cytomegalovirus expressing mouse zona pellucida 3
Megan L Lloyd et al. Biol Reprod. 2003 Jun.
Abstract
Immunocontraception, the prevention of oocyte fertilization through immunological means, could potentially be used to control plaguing mouse populations in Australia. This paper describes the construction of a mouse-specific betaherpesvirus, murine cytomegalovirus, which has been engineered to express the murine zona pellucida 3 (ZP3) gene. A single inoculation of this recombinant virus resulted in almost complete infertility, persistent anti-ZP3 antibody production, and profound changes to ovarian morphology in BALB/c mice in the absence of significant virus replication during the acute phase of infection. Murine cytomegalovirus may prove to be useful as a vector for the delivery of a mouse-specific immunocontraceptive agent to target populations of wild mice in the field.
Similar articles
- Immunoglobulin to zona pellucida 3 mediates ovarian damage and infertility after contraceptive vaccination in mice.
Lloyd ML, Papadimitriou JM, O'Leary S, Robertson SA, Shellam GR. Lloyd ML, et al. J Autoimmun. 2010 Aug;35(1):77-85. doi: 10.1016/j.jaut.2010.03.002. Epub 2010 Apr 10. J Autoimmun. 2010. PMID: 20382503 - Immunization with recombinant murine cytomegalovirus expressing murine zona pellucida 3 causes permanent infertility in BALB/c mice due to follicle depletion and ovulation failure.
O'Leary S, Lloyd ML, Shellam GR, Robertson SA. O'Leary S, et al. Biol Reprod. 2008 Nov;79(5):849-60. doi: 10.1095/biolreprod.108.067884. Epub 2008 Jul 30. Biol Reprod. 2008. PMID: 18667753 - Prior infection with murine cytomegalovirus (MCMV) limits the immunocontraceptive effects of an MCMV vector expressing the mouse zona-pellucida-3 protein.
Gorman S, Lloyd ML, Smith LM, McWhorter AR, Lawson MA, Redwood AJ, Shellam GR. Gorman S, et al. Vaccine. 2008 Jul 23;26(31):3860-9. doi: 10.1016/j.vaccine.2008.05.020. Epub 2008 Jun 2. Vaccine. 2008. PMID: 18573574 - Current status of virally vectored immunocontraception for biological control of mice.
Hardy CM. Hardy CM. Soc Reprod Fertil Suppl. 2007;63:495-506. Soc Reprod Fertil Suppl. 2007. PMID: 17566294 Review. - Biological control of vertebrate pests using virally vectored immunocontraception.
Hardy CM, Hinds LA, Kerr PJ, Lloyd ML, Redwood AJ, Shellam GR, Strive T. Hardy CM, et al. J Reprod Immunol. 2006 Oct;71(2):102-11. doi: 10.1016/j.jri.2006.04.006. Epub 2006 Jul 25. J Reprod Immunol. 2006. PMID: 16870262 Review.
Cited by
- Silkworm recombinant bovine zona pellucida protein 4 (bZP4) as a potential female immunocontraceptive antigen; impaired sperm-oocyte interaction and ovarian dysfunction.
Tatematsu KI, Ikeda M, Wakabayashi Y, Yamamura T, Kikuchi K, Noguchi J, Sezutsu H. Tatematsu KI, et al. J Reprod Dev. 2021 Dec 14;67(6):402-406. doi: 10.1262/jrd.2021-103. Epub 2021 Oct 21. J Reprod Dev. 2021. PMID: 34670878 Free PMC article. - Vaccine Vectors Harnessing the Power of Cytomegaloviruses.
Ynga-Durand MA, Dekhtiarenko I, Cicin-Sain L. Ynga-Durand MA, et al. Vaccines (Basel). 2019 Oct 17;7(4):152. doi: 10.3390/vaccines7040152. Vaccines (Basel). 2019. PMID: 31627457 Free PMC article. Review. - Efficacy and Safety of Native and Recombinant Zona Pellucida Immunocontraceptive Vaccines Formulated with Non-Freund's Adjuvants in Donkeys.
French H, Segabinazzi L, Middlebrooks B, Peterson E, Schulman M, Roth R, Crampton M, Conan A, Marchi S, Gilbert T, Knobel D, Bertschinger H. French H, et al. Vaccines (Basel). 2022 Nov 24;10(12):1999. doi: 10.3390/vaccines10121999. Vaccines (Basel). 2022. PMID: 36560409 Free PMC article. - Promising Cytomegalovirus-Based Vaccine Vector Induces Robust CD8+ T-Cell Response.
Liu J, Jaijyan DK, Tang Q, Zhu H. Liu J, et al. Int J Mol Sci. 2019 Sep 10;20(18):4457. doi: 10.3390/ijms20184457. Int J Mol Sci. 2019. PMID: 31510028 Free PMC article. Review. - Cytomegalovirus and immunotherapy: opportunistic pathogen, novel target for cancer and a promising vaccine vector.
Quinn M, Erkes DA, Snyder CM. Quinn M, et al. Immunotherapy. 2016 Feb;8(2):211-21. doi: 10.2217/imt.15.110. Epub 2016 Jan 20. Immunotherapy. 2016. PMID: 26786895 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources